The Cardiometabolic Medical Science Liaison (MSL) is a field-based scientific expert responsible for building trusted peer-to-peer relationships with healthcare professionals, researchers, and key opinion leaders across Australia.Starting with a fresh canvas, this role offers an exciting opportunity to build something meaningful from the ground up—playing a critical role in establishing Specialty Care at Sobi in Australia and creating waves through scientific leadership, purposeful partnerships, and a clear focus on unmet patient needs. Operating within a pre-registration environment, the MSL will help shape Sobi’s cardiometabolic presence, with particular emphasis on severe hypertriglyceridaemia (sHTG), familial chylomicronaemia syndrome (FCS), hypertriglyceridaemia-associated acute pancreatitis, and related metabolic disorders. By engaging leading experts in lipidology, endocrinology, hepatology, gastroenterology, cardiology, and metabolic medicine, the MSL will advance disease understanding, identify unmet medical needs, and help lay the foundations for future launch readiness.As the primary medical field representative, the MSL will serve as the scientific interface between Sobi and the external healthcare community, delivering high-quality scientific exchange, facilitating medical education, generating strategic insights, and developing long-term scientific partnerships that improve patient care and outcomes.Key contributions include:Developing deep scientific expertise in cardiometabolic disease, rare lipid disorders, and related conditionsRepresenting Sobi in supporting the quality use of medicines and favourable patient outcomesBuilding and strengthening a network of partnerships with KOLs in lipidology, endocrinology, hepatology, gastroenterology, cardiology, and metabolic medicineDelivering medical education initiatives and high-quality scientific exchangeContributing to strategic planning, medical field activities, and launch readinessProviding field support, medical insights, and evidence generation activities across Australia This is more than a traditional MSL role—it is an opportunity to be part of a bigger picture and help build the future of Specialty Care at Sobi in Australia. Starting with a fresh canvas, you will have the freedom to bring ideas, take initiative, and contribute beyond the traditional MSL remit through strategic medical projects, scientific partnerships, and cross-functional collaboration, while maintaining clear medical independence and compliance boundaries. At its core, this field-based role provides non-promotional educational, scientific and research support for the Sobi cardiometabolic portfolio, building trusted professional relationships with leading opinion leaders in lipidology, endocrinology, hepatology, gastroenterology, cardiology, and metabolic medicine across Australia.You will help shape and proactively drive the local medical plan, turning field insights into meaningful initiatives and bringing fresh thinking to unmet medical needs, in accordance with local laws and the Medicines Australia Code of Conduct. As a strong advocate for patients, you will increase awareness of medical and patient needs, deepen understanding of data gaps and potential ways to address them, and support timely access to therapies.You will play a critical role in establishing Specialty Care at Sobi and strengthening its presence and scientific credibility within the Australian cardiometabolic community. This is your chance to help create waves through purposeful scientific leadership, contribute to something bigger than an individual territory, and see your ideas help shape a growing medical function. Working within a pre-registration environment, you will build the scientific foundation for future commercial activities and launch readiness, while keeping all medical engagement balanced, non-promotional, and patient-focused. ESSENTIAL RESPONSIBILITIESIncluding, but not limited to, the following:Key Opinion Leader EngagementDevelop and maintain strong scientific relationships with national, regional, and emerging key opinion leaders (KOLs) across AustraliaCreate and execute strategic engagement plans for healthcare professionals and researchers in lipidology, endocrinology, hepatology, gastroenterology, cardiology, and metabolic medicineIdentify and cultivate relationships with future scientific leaders, investigators, and centres of excellenceEstablish productive partnerships with professional societies, academic institutions, scientific networks, and healthcare organisations relevant to cardiometabolic diseaseConduct territory-specific disease, pathway, and medical expert mappingAct as a trusted scientific partner through ongoing, compliant, peer-to-peer scientific exchangeEnsure >75% of time is spent on HCP interactions, HCP-focused activities, and/or in-field activitiesScientific Exchange and Medical EducationDeliver high-quality, non-promotional scientific exchange with healthcare professionals and researchersDemonstrate and communicate clinical evidence, disease burden, unmet medical needs, and emerging scientific data relevant to cardiometabolic diseasesDeliver peer-level presentations to HCPs and group meetingsEducate and engage clinical specialists, academic faculty, medical researchers, hospital-based healthcare professionals, pharmacists, and allied health professionalsCoordinate and support scientific meetings, educational workshops, advisory boards, congress activities, and symposiaRepresent Sobi at scientific congresses and major medical meetingsRespond appropriately to unsolicited scientific and medical information requests in accordance with company policies and local regulationsEnsure good reporting and interactions with Medical colleagues from other affiliates; share and receive best practicesDisease Area LeadershipDevelop and maintain deep scientific expertise in: severe hypertriglyceridaemia (sHTG), familial chylomicronaemia syndrome (FCS), hypertriglyceridaemia-associated acute pancreatitis, rare lipid disorders, and cardiometabolic diseaseSupport disease awareness activities aimed at improving recognition, diagnosis, and management of patients living with rare lipid disordersFacilitate scientific discussions regarding disease burden, diagnostic pathways, referral patterns, and patient management challengesMaintain a comprehensive understanding of the evolving scientific and clinical landscapeMedical Insights and Landscape DevelopmentGather and communicate insights from healthcare professionals regarding unmet medical needs, current treatment practices, diagnostic challenges, referral pathways, future research opportunities, and emerging scientific trendsIdentify and communicate key clinical and research insights from key opinion leaders to help formulate Sobi research and development, and business strategiesDevelop and maintain stakeholder maps and engagement plansProvide strategic field insights that support understanding of the Australian cardiometabolic landscape and future launch readiness activitiesResearch and Scientific CollaborationIdentify investigators, treatment centres, and research networks with an interest in cardiometabolic and rare lipid diseasesRespond and support unsolicited requests for investigator-initiated studies (IISs)Explore opportunities for scientific collaboration and evidence generationSupport the identification of sites and investigators for future clinical research activitiesFacilitate scientific discussion regarding ongoing and emerging clinical research programmesFoster partnerships that contribute to advancing disease understanding and improving patient outcomesCompliance and ReportingConduct all activities in compliance with the Medicines Australia Code of Conduct, TGA requirements, pharmacovigilance obligations, and Sobi policiesEnsure timely and accurate reporting regarding compliance, adverse events, safety documentation, and stakeholder interactionsEnsure all external interactions remain scientific, balanced, and non-promotional, particularly within a pre-registration environmentDemonstrating the highest standards of ethics, transparency, and patient focus in all activitiesSobi Australia operates as an integrated cross-functional customer-facing team. This role is expected to fulfil the medical affairs components of that engagement and will provide appropriate support to cross-functional team members and projects 
